(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Ondine Biomedical Inc shares were up on early Friday afternoon, after the company announced plans to conduct a fundraise to support commercialisation of its flagship antimicrobial therapy. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Ondine Biomedical Inc on Monday reported that a study undertaken at the Mazankowski Alberta Heart Institute demonstrated a 32% reduction in cardiac surgical site infections through the use of its Steriwave product as a replacement for the antibiotic Mupirocin. Read More
(Alliance News) - Ondine Biomedical Inc on Wednesday said that Steriwave, a light-activated antimicrobial, has been approved by HCA Healthcare UK for use in its healthcare facilities. Read More
(Alliance News) - Ondine Biomedical Inc on Thursday said by introducing its Steriwave product into the intensive care unit market could expand its revenue potential. Read More
(Alliance News) - Ondine Biomedical Inc on Thursday appointed a new interim chief financial officer, following the resignation of former CFO Joseph Errico. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Ondine Biomedical Inc - Vancouver-based life sciences company - Announces significant commercial progress to date in 2024, ahead of management's expectations. Says Ondine's Steriwave technology is deploying in eight new healthcare facilities, including six new hospitals. This brings the total number of hospitals to 22, representing a 38% increase year-to-date and nearly quadruple the number a year ago. Two orthopedic surgeon group practices in the Toronto area will also shortly begin offering Steriwave to patients undergoing elective orthopedic procedures. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Ondine Biomedical Inc on Wednesday said that the research it presented at a conference in San Francisco proves the efficacy of its Steriwave nasal photo disinfection system. Read More
Ondine Biomedical Inc - Vancouver-based life sciences company - Appoints Joseph Errico as chief financial officer, though doesn't provide start date. Says Errico has successfully founded, sold, or taken public several medical device and pharmaceutical companies, including ElectroCore, Fastenetix, K2 Medical Systems, AD4-Pharma, E2, and SpineCore. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Ondine Biomedical Inc on Tuesday said it raised around GBP2.8 million after successfully completing a placing and subscription of new shares. Read More
